Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002638-19Phase 4Completed
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Spironolactone plus usual analgesia with Placebo plus usual analgesia (2 arms). Primary endpoint: Change in WOMAC pain subscale at 12 weeks. Started Sep 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002638-19.